Importance of minimal residual viremia for relapse prediction in patients with chronic hepatitis C genotype 1 infection.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 22021919.
- Also identified by DOI 10.1093/cid/cir670.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study demonstrates that a more precise prediction of the individual relapse risk in chronic hepatitis C virus genotype 1 infection can be obtained by kinetics of minimal residual viremia at weeks 4, 8, and 12 in combination with levels of baseline viremia. These data may also help to further individualize new protease inhibitor-based triple therapy regimens.
Medical subject headings
- Hepacivirus
- Hepatitis C, Chronic
- Viral Load
- Viremia